Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CDK Global, Inc.
Report date July 06, 2022 · Filed July 06, 2022
Section 16 reporting ended · disclosed 2022-07-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2022-07-06 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-07-06 · Grant · Acquired 79,750 · Balance 170,733 F1: Represents shares of common stock, par value $0.01 per share (each, a "Share"), of CDK Global, Inc. (the "Company") that are subject to performance-based restricted stock units ("PSUs"). Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), among the Company, Central Parent LLC ("Parent") and Central Merger Sub Inc. ("Merger Sub"), on July 6, 2022 (the "Closing Date"), Merger Sub merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"), and each PSU outstanding immediately prior to the consummation of the Merger became fully vested at the greater of the target and actual performance measured through the Closing Date (with the performance in respect of any fiscal year commencing after the 2022 fiscal year being at target performance), and was canceled and converted into the right to receive, for each Share subject to such then-vested PSU, $54.87 in cash without interest. Row 2 · 2022-07-06 · Disposition to issuer · Disposed 170,733 · Balance 0 F2: Pursuant to the Merger Agreement, at the effective time of the Merger, each Share was canceled and converted into the right to receive $54.87 in cash without interest. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $55.35 | Direct | 0 |
Reported balance
After 2022-07-06 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-07-06 · Disposition to issuer · Disposed 22,288 · Balance 0 F3: Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Merger, whether then unvested or vested, by virtue of the Merger and without any action by the holder, was canceled and converted into only the right to receive an amount in cash, without interest, equal to the product of (x) the number of Shares issuable under such option and (y) the excess, if any, of (i) $54.87 over (ii) the exercise price payable in respect of each Share issuable under such option (the "Option Consideration"); provided, however, that the Option Consideration for each option with an exercise price equal to or greater than $54.87 was $0. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock, par value $0.01 per share (each, a "Share"), of CDK Global, Inc. (the "Company") that are subject to performance-based restricted stock units ("PSUs"). Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), among the Company, Central Parent LLC ("Parent") and Central Merger Sub Inc. ("Merger Sub"), on July 6, 2022 (the "Closing Date"), Merger Sub merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"), and each PSU outstanding immediately prior to the consummation of the Merger became fully vested at the greater of the target and actual performance measured through the Closing Date (with the performance in respect of any fiscal year commencing after the 2022 fiscal year being at target performance), and was canceled and converted into the right to receive, for each Share subject to such then-vested PSU, $54.87 in cash without interest.
F2: Pursuant to the Merger Agreement, at the effective time of the Merger, each Share was canceled and converted into the right to receive $54.87 in cash without interest.
F3: Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Merger, whether then unvested or vested, by virtue of the Merger and without any action by the holder, was canceled and converted into only the right to receive an amount in cash, without interest, equal to the product of (x) the number of Shares issuable under such option and (y) the excess, if any, of (i) $54.87 over (ii) the exercise price payable in respect of each Share issuable under such option (the "Option Consideration"); provided, however, that the Option Consideration for each option with an exercise price equal to or greater than $54.87 was $0.
RB GLOBAL INC.
Report date March 20, 2023 · Filed March 23, 2023
Section 16 reporting ended · disclosed 2023-03-23. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 06, 2023 Filed Mar 7, 2023 18:57 UTC | RB GLOBAL INC. RBA · Entity 3351 | GrantDeferred Share Units · Derivative | 522 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016626 · doc4.xml · derivative · entry 1 Shah Mahesh · CIK 0001775045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,456 Underlying: Common Shares · 522 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit ("DSU") represents the economic equivalent of one RBA common share. F2 · derivative.exercise_date: Following the reporting person ceasing to hold any position as a director of RBA or any of its subsidiaries and not otherwise being employed by RBA or any of its subsidiaries ("Termination"), a lump sum cash payment will be made by RBA to the reporting person, net of tax withholding, calculated by multiplying the number of DSUs by the fair market value of one RBA common share as of (i) the 24th business day after the first publication by or on behalf of RBA of interim financial statements and MD&A for the fiscal quarter of the corporation following such Termination or (ii) where the Termination occurs in RBA's fourth fiscal quarter, the 24th business day (or such fewer number of business days as may be determined by the Committee) after the first publication by or on behalf of RBA of annual financial statements and MD&As for such fiscal year of RBA. F2 · derivative.expiration_date: Following the reporting person ceasing to hold any position as a director of RBA or any of its subsidiaries and not otherwise being employed by RBA or any of its subsidiaries ("Termination"), a lump sum cash payment will be made by RBA to the reporting person, net of tax withholding, calculated by multiplying the number of DSUs by the fair market value of one RBA common share as of (i) the 24th business day after the first publication by or on behalf of RBA of interim financial statements and MD&A for the fiscal quarter of the corporation following such Termination or (ii) where the Termination occurs in RBA's fourth fiscal quarter, the 24th business day (or such fewer number of business days as may be determined by the Committee) after the first publication by or on behalf of RBA of annual financial statements and MD&As for such fiscal year of RBA. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 19:01 UTC | RB GLOBAL INC. RBA · Entity 3351 | GrantDividend Equivalent Rights (DSUs) · Derivative | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016185 · doc4.xml · derivative · entry 1 Shah Mahesh · CIK 0001775045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10 Underlying: Common Shares · 4 shares Expires not disclosed F1 · derivative.exercise_price: The dividend equivalent rights accrued in respect of the reporting person's deferred share units, and become exercisable and payable concurrently with the deferred share units. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RBA common share. F1 · derivative.exercise_date: The dividend equivalent rights accrued in respect of the reporting person's deferred share units, and become exercisable and payable concurrently with the deferred share units. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RBA common share. F1 · derivative.expiration_date: The dividend equivalent rights accrued in respect of the reporting person's deferred share units, and become exercisable and payable concurrently with the deferred share units. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RBA common share. Read SEC document |
| December 14, 2022 Filed Dec 15, 2022 16:14 UTC | RB GLOBAL INC. RBA · Entity 3351 | GrantDividend Equivalent Rights (DSUs) · Derivative | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-061344 · doc4.xml · derivative · entry 1 Shah Mahesh · CIK 0001775045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6 Underlying: Common Shares · 5 shares Expires not disclosed F1 · derivative.exercise_price: The dividend equivalent rights accrued in respect of the reporting person's deferred share units, and become exercisable and payable concurrently with the deferred share units. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RBA common share. F1 · derivative.exercise_date: The dividend equivalent rights accrued in respect of the reporting person's deferred share units, and become exercisable and payable concurrently with the deferred share units. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RBA common share. F1 · derivative.expiration_date: The dividend equivalent rights accrued in respect of the reporting person's deferred share units, and become exercisable and payable concurrently with the deferred share units. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RBA common share. Read SEC document |
| November 14, 2022 Filed Nov 15, 2022 20:15 UTC | RB GLOBAL INC. RBA · Entity 3351 | GrantDeferred Share Units · Derivative | 604 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-056961 · doc4.xml · derivative · entry 1 Shah Mahesh · CIK 0001775045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 934 Underlying: Common Shares · 604 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit ("DSU") represents the economic equivalent of one RBA common share. F2 · derivative.exercise_date: Following the reporting person ceasing to hold any position as a director of RBA or any of its subsidiaries and not otherwise being employed by RBA or any of its subsidiaries ("Termination"), a lump sum cash payment will be made by RBA to the reporting person, net of tax withholding, calculated by multiplying the number of DSUs by the fair market value of one RBA common share as of (i) the 24th business day after the first publication by or on behalf of RBA of interim financial statements and MD&A for the fiscal quarter of the corporation following such Termination or (ii) where the Termination occurs in RBA's fourth fiscal quarter, the 24th business day (or such fewer number of business days as may be determined by the Committee) after the first publication by or on behalf of RBA of annual financial statements and MD&As for such fiscal year of RBA. F2 · derivative.expiration_date: Following the reporting person ceasing to hold any position as a director of RBA or any of its subsidiaries and not otherwise being employed by RBA or any of its subsidiaries ("Termination"), a lump sum cash payment will be made by RBA to the reporting person, net of tax withholding, calculated by multiplying the number of DSUs by the fair market value of one RBA common share as of (i) the 24th business day after the first publication by or on behalf of RBA of interim financial statements and MD&A for the fiscal quarter of the corporation following such Termination or (ii) where the Termination occurs in RBA's fourth fiscal quarter, the 24th business day (or such fewer number of business days as may be determined by the Committee) after the first publication by or on behalf of RBA of annual financial statements and MD&As for such fiscal year of RBA. Read SEC document |
| September 14, 2022 Filed Sep 15, 2022 18:07 UTC | RB GLOBAL INC. RBA · Entity 3351 | GrantDividend Equivalent Rights (DSUs) · Derivative | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-050022 · doc4.xml · derivative · entry 1 Shah Mahesh · CIK 0001775045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1 Underlying: Common Shares · 1 shares Expires not disclosed F1 · derivative.exercise_price: The dividend equivalent rights accrued in respect of the reporting person's deferred share units, and become exercisable and payable concurrently with the deferred share units. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RBA common share. F1 · derivative.exercise_date: The dividend equivalent rights accrued in respect of the reporting person's deferred share units, and become exercisable and payable concurrently with the deferred share units. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RBA common share. F1 · derivative.expiration_date: The dividend equivalent rights accrued in respect of the reporting person's deferred share units, and become exercisable and payable concurrently with the deferred share units. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RBA common share. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 16:48 UTC | RB GLOBAL INC. RBA · Entity 3351 | GrantDeferred Share Units · Derivative | 330 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-045948 · doc4.xml · derivative · entry 1 Shah Mahesh · CIK 0001775045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 330 Underlying: Common Shares · 330 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit ("DSU") represents the economic equivalent of one RBA common share. F2 · derivative.exercise_date: Following the reporting person ceasing to hold any position as a director of RBA or any of its subsidiaries and not otherwise being employed by RBA or any of its subsidiaries ("Termination"), a lump sum cash payment will be made by RBA to the reporting person, net of tax withholding, calculated by multiplying the number of DSUs by the fair market value of one RBA common share as of (i) the 24th business day after the first publication by or on behalf of RBA of interim financial statements and MD&A for the fiscal quarter of the corporation following such Termination or (ii) where the Termination occurs in RBA's fourth fiscal quarter, the 24th business day (or such fewer number of business days as may be determined by the Committee) after the first publication by or on behalf of RBA of annual financial statements and MD&As for such fiscal year of RBA. F2 · derivative.expiration_date: Following the reporting person ceasing to hold any position as a director of RBA or any of its subsidiaries and not otherwise being employed by RBA or any of its subsidiaries ("Termination"), a lump sum cash payment will be made by RBA to the reporting person, net of tax withholding, calculated by multiplying the number of DSUs by the fair market value of one RBA common share as of (i) the 24th business day after the first publication by or on behalf of RBA of interim financial statements and MD&A for the fiscal quarter of the corporation following such Termination or (ii) where the Termination occurs in RBA's fourth fiscal quarter, the 24th business day (or such fewer number of business days as may be determined by the Committee) after the first publication by or on behalf of RBA of annual financial statements and MD&As for such fiscal year of RBA. Read SEC document |
| July 06, 2022 Filed Jul 6, 2022 19:30 UTC | CDK Global, Inc. CDK · Entity 125554 | Disposition to issuerOption (right to buy) · Derivative | 22,288 | Not disclosed Strike: $55.35 | Not disclosed |
DisclosureSEC source: 0000950142-22-002139 · es220267547_4-shah.xml · derivative · entry 3 Shah Mahesh · CIK 0001775045 · Chief Product & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,288 shares Expires not disclosed F3 · price: Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Merger, whether then unvested or vested, by virtue of the Merger and without any action by the holder, was canceled and converted into only the right to receive an amount in cash, without interest, equal to the product of (x) the number of Shares issuable under such option and (y) the excess, if any, of (i) $54.87 over (ii) the exercise price payable in respect of each Share issuable under such option (the "Option Consideration"); provided, however, that the Option Consideration for each option with an exercise price equal to or greater than $54.87 was $0. F3 · derivative.exercise_date: Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Merger, whether then unvested or vested, by virtue of the Merger and without any action by the holder, was canceled and converted into only the right to receive an amount in cash, without interest, equal to the product of (x) the number of Shares issuable under such option and (y) the excess, if any, of (i) $54.87 over (ii) the exercise price payable in respect of each Share issuable under such option (the "Option Consideration"); provided, however, that the Option Consideration for each option with an exercise price equal to or greater than $54.87 was $0. F3 · derivative.expiration_date: Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Merger, whether then unvested or vested, by virtue of the Merger and without any action by the holder, was canceled and converted into only the right to receive an amount in cash, without interest, equal to the product of (x) the number of Shares issuable under such option and (y) the excess, if any, of (i) $54.87 over (ii) the exercise price payable in respect of each Share issuable under such option (the "Option Consideration"); provided, however, that the Option Consideration for each option with an exercise price equal to or greater than $54.87 was $0. Read SEC document |
| July 06, 2022 Filed Jul 6, 2022 19:30 UTC | CDK Global, Inc. CDK · Entity 125554 | Disposition to issuerCommon Stock | 170,733 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950142-22-002139 · es220267547_4-shah.xml · nonDerivative · entry 2 Shah Mahesh · CIK 0001775045 · Chief Product & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: Pursuant to the Merger Agreement, at the effective time of the Merger, each Share was canceled and converted into the right to receive $54.87 in cash without interest. Read SEC document |
| July 06, 2022 Filed Jul 6, 2022 19:30 UTC | CDK Global, Inc. CDK · Entity 125554 | GrantCommon Stock | 79,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950142-22-002139 · es220267547_4-shah.xml · nonDerivative · entry 1 Shah Mahesh · CIK 0001775045 · Chief Product & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,733 F1 · shares: Represents shares of common stock, par value $0.01 per share (each, a "Share"), of CDK Global, Inc. (the "Company") that are subject to performance-based restricted stock units ("PSUs"). Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), among the Company, Central Parent LLC ("Parent") and Central Merger Sub Inc. ("Merger Sub"), on July 6, 2022 (the "Closing Date"), Merger Sub merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"), and each PSU outstanding immediately prior to the consummation of the Merger became fully vested at the greater of the target and actual performance measured through the Closing Date (with the performance in respect of any fiscal year commencing after the 2022 fiscal year being at target performance), and was canceled and converted into the right to receive, for each Share subject to such then-vested PSU, $54.87 in cash without interest. F1 · price: Represents shares of common stock, par value $0.01 per share (each, a "Share"), of CDK Global, Inc. (the "Company") that are subject to performance-based restricted stock units ("PSUs"). Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), among the Company, Central Parent LLC ("Parent") and Central Merger Sub Inc. ("Merger Sub"), on July 6, 2022 (the "Closing Date"), Merger Sub merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"), and each PSU outstanding immediately prior to the consummation of the Merger became fully vested at the greater of the target and actual performance measured through the Closing Date (with the performance in respect of any fiscal year commencing after the 2022 fiscal year being at target performance), and was canceled and converted into the right to receive, for each Share subject to such then-vested PSU, $54.87 in cash without interest. Read SEC document |
| May 02, 2022 Filed May 3, 2022 18:04 UTC | CDK Global, Inc. CDK · Entity 125554 | Tax withholdingCommon Stock | 203 | $54.37 | $11,037.11 |
DisclosureSEC source: 0000950142-22-001542 · es220249228_4-shah.xml · nonDerivative · entry 1 Shah Mahesh · CIK 0001775045 · Chief Product & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,983 Read SEC document |
| September 17, 2021 Filed Sep 20, 2021 18:34 UTC | CDK Global, Inc. CDK · Entity 125554 | Tax withholdingCommon Stock | 6,626 | $42.35 | $280,611.10 |
DisclosureSEC source: 0000950142-21-002953 · es210185400_4-shah.xml · nonDerivative · entry 2 Shah Mahesh · CIK 0001775045 · Chief Product & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,186 Read SEC document |
| September 16, 2021 Filed Sep 20, 2021 18:34 UTC | CDK Global, Inc. CDK · Entity 125554 | GrantCommon Stock | 42,263 | $0.00 | $0.00 |
DisclosureSEC source: 0000950142-21-002953 · es210185400_4-shah.xml · nonDerivative · entry 1 Shah Mahesh · CIK 0001775045 · Chief Product & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,812 F1 · price: The reported transaction reflects the grant of Restricted Stock Units under the Issuer's 2014 Omnibus Award Plan and represents a like number of shares of the Issuer's common stock. These Restricted Stock Units vest in three equal installments on September 16, 2022, September 12, 2023, and September 12, 2024. Upon vesting these Restricted Stock Units will settle in shares of the Issuer's common stock. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 18:37 UTC | CDK Global, Inc. CDK · Entity 125554 | Tax withholdingCommon Stock | 1,515 | $42.43 | $64,281.45 |
DisclosureSEC source: 0000950142-21-002902 · es210184043_4-shah.xml · nonDerivative · entry 1 Shah Mahesh · CIK 0001775045 · Chief Product & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,549 Read SEC document |
| August 26, 2021 Filed Aug 30, 2021 18:39 UTC | CDK Global, Inc. CDK · Entity 125554 | Tax withholdingCommon Stock | 1,331 | $40.97 | $54,531.07 |
DisclosureSEC source: 0000950142-21-002774 · es210181049_4-shah.xml · nonDerivative · entry 1 Shah Mahesh · CIK 0001775045 · Chief Product & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,064 Read SEC document |
| August 13, 2021 Filed Aug 17, 2021 20:32 UTC | CDK Global, Inc. CDK · Entity 125554 | GrantCommon Stock | 2,797 | $0.00 | $0.00 |
DisclosureSEC source: 0000950142-21-002664 · es210178232_4-shah.xml · nonDerivative · entry 1 Shah Mahesh · CIK 0001775045 · Chief Product & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,395 Read SEC document |
| April 30, 2021 Filed May 3, 2021 18:30 UTC | CDK Global, Inc. CDK · Entity 125554 | Tax withholdingCommon Stock | 1,289 | $53.59 | $69,077.51 |
DisclosureSEC source: 0000950142-21-001518 · es210149168_4-shah.xml · nonDerivative · entry 2 Shah Mahesh · CIK 0001775045 · Chief Product & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,598 Read SEC document |
| April 30, 2021 Filed May 3, 2021 18:30 UTC | CDK Global, Inc. CDK · Entity 125554 | Tax withholdingCommon Stock | 280 | $53.59 | $15,005.20 |
DisclosureSEC source: 0000950142-21-001518 · es210149168_4-shah.xml · nonDerivative · entry 1 Shah Mahesh · CIK 0001775045 · Chief Product & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,887 Read SEC document |
| September 17, 2020 Filed Sep 21, 2020 18:33 UTC | CDK Global, Inc. CDK · Entity 125554 | GrantCommon Stock | 41,426 | $0.00 | $0.00 |
DisclosureSEC source: 0000950142-20-002290 · es200101489_4-shah.xml · nonDerivative · entry 1 Shah Mahesh · CIK 0001775045 · Chief Product & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,167 F1 · price: The reported transaction reflects the grant of Restricted Stock Units under the Issuer's 2014 Omnibus Award Plan and represents a like number of shares of the Issuer's common stock. These Restricted Stock Units vest in three equal installments on September 17, 2021, September 17, 2022, and September 17, 2023. Upon vesting these Restricted Stock Units will settle in shares of the Issuer's common stock. Read SEC document |
| September 11, 2020 Filed Sep 15, 2020 18:33 UTC | CDK Global, Inc. CDK · Entity 125554 | Tax withholdingCommon Stock | 1,451 | $43.83 | $63,597.33 |
DisclosureSEC source: 0000950142-20-002234 · es2001168_4-shah.xml · nonDerivative · entry 1 Shah Mahesh · CIK 0001775045 · Chief Product & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,741 Read SEC document |
| May 12, 2020 Filed May 14, 2020 18:04 UTC | CDK Global, Inc. CDK · Entity 125554 | Tax withholdingCommon Stock | 2,882 | $39.42 | $113,608.44 |
DisclosureSEC source: 0000950142-20-001355 · es2000749_4-shah.xml · nonDerivative · entry 2 Shah Mahesh · CIK 0001775045 · Chief Product & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,192 Read SEC document |
| May 12, 2020 Filed May 14, 2020 18:04 UTC | CDK Global, Inc. CDK · Entity 125554 | Tax withholdingCommon Stock | 268 | $39.42 | $10,564.56 |
DisclosureSEC source: 0000950142-20-001355 · es2000749_4-shah.xml · nonDerivative · entry 1 Shah Mahesh · CIK 0001775045 · Chief Product & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,074 Read SEC document |
| September 12, 2019 Filed Sep 16, 2019 19:59 UTC | CDK Global, Inc. CDK · Entity 125554 | GrantCommon Stock | 9,548 | $0.00 | $0.00 |
DisclosureSEC source: 0000950142-19-001972 · es1901100_4-shah.xml · nonDerivative · entry 1 Shah Mahesh · CIK 0001775045 · Chief Product & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,342 F1 · price: The reported transaction reflects the grant of Restricted Stock Units under the Issuer's 2014 Omnibus Award Plan and represents a like number of shares of the Issuer's common stock. These Restricted Stock Units vest in three equal installments on September 11, 2020, September 10, 2021, and September 12, 2022. Upon vesting these Restricted Stock Units will settle in shares of the Issuer's common stock. Read SEC document |
| May 02, 2019 Filed May 6, 2019 21:00 UTC | CDK Global, Inc. CDK · Entity 125554 | GrantStock Option (Right to Buy) · Derivative | 22,288 | $0.00 Strike: $55.35 | $0.00 |
DisclosureSEC source: 0000950142-19-001021 · es1900637_4-shah.xml · derivative · entry 3 Shah Mahesh · CIK 0001775045 · Chief Product & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,288 Underlying: Common Stock · 22,288 shares Expires 2029-05-02 F3 · derivative.exercise_date: The options become exercisable in four equal installments on May 2, 2020, 2021, 2022 and 2023. Read SEC document |
| May 02, 2019 Filed May 6, 2019 21:00 UTC | CDK Global, Inc. CDK · Entity 125554 | GrantCommon Stock | 9,033 | $0.00 | $0.00 |
DisclosureSEC source: 0000950142-19-001021 · es1900637_4-shah.xml · nonDerivative · entry 2 Shah Mahesh · CIK 0001775045 · Chief Product & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,794 F2 · price: The reported transaction reflects the grant of Restricted Stock Units under the Plan. The Restricted Stock Units vest in two installments of 70% on May 2, 2020, and 30% on May 2, 2021. Read SEC document |
| May 02, 2019 Filed May 6, 2019 21:00 UTC | CDK Global, Inc. CDK · Entity 125554 | GrantCommon Stock | 1,761 | $0.00 | $0.00 |
DisclosureSEC source: 0000950142-19-001021 · es1900637_4-shah.xml · nonDerivative · entry 1 Shah Mahesh · CIK 0001775045 · Chief Product & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,761 F1 · price: The reported transaction reflects the grant of Restricted Stock Units under the Issuer's 2014 Omnibus Award Plan (the "Plan"). The Restricted Stock Units vest in three equal installments on May 2, 2020, 2021, and 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.